JOIN Enterprise expands global reach with fiberglass casting tape and splints
JOIN Enterprise Co., Ltd. is pushing its orthopedic device business into more than 50 countries with synthetic casting tape and splint products used in fracture and trauma care. The South Korean maker is also extending its hospital-tested material technology into consumer healthcare, including a hydrocolloid acne patch launched in 2025.
Why it matters: - JOIN Enterprise is scaling a core set of orthopedic immobilization products that replace traditional plaster casts with lighter, faster-setting alternatives. - The company’s move into consumer healthcare signals a wider commercial use for medical-device material science. - Exports to more than 50 countries, including North America and Europe, show the products have moved beyond a domestic market.
What happened: - JOIN Enterprise Co., Ltd., a South Korean orthopedic medical device maker, is expanding its global presence with synthetic fiberglass casting tape and orthopedic splint systems. - The company has focused exclusively on orthopedic immobilization devices for more than 30 years. - JOIN Enterprise said the products are used in fracture and trauma care. - The company also said it will meet global buyers and partners at MEDICA in November in Dusseldorf, Germany, at Hall 5, Booth K12.
The details: - The flagship fiberglass casting tape is designed as a replacement for traditional plaster casts. - JOIN Enterprise says the tape offers lightweight structure, high strength, fast curing time, excellent moldability, and improved patient comfort. - The orthopedic splint products are used in hospitals and medical institutions to stabilize and protect injured limbs. - The splints are positioned for both emergency care and follow-up care. - Every cast and splint product is manufactured under a quality management system built on three decades of production technology and continued R&D investment. - The company’s exports now reach more than 50 countries. - The company’s market footprint includes North America and Europe. - JOIN Enterprise expanded into consumer healthcare with a hydrocolloid acne patch launched in 2025. - The acne patch uses medical-grade material technology for skin protection and blemish care. - The company says the acne patch is designed to deliver enhanced safety and adhesion through medical device-level quality standards.
Between the lines: - JOIN Enterprise is trying to convert clinical credibility into broader consumer demand. - The company is framing product quality as the bridge between hospital use and everyday healthcare items. - MEDICA gives JOIN Enterprise a major global sales venue at a time when the company is seeking more international buyers.
What's next: - JOIN Enterprise plans to keep advancing orthopedic device technology. - The company also plans to expand its global footprint and develop more medical device-based consumer healthcare products. - The annual MEDICA appearance will give the company another chance to deepen distributor and buyer relationships.
The bottom line: - JOIN Enterprise is using orthopedic device expertise to grow abroad and build a second business in consumer healthcare.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
South Korea Technology Today
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.